Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.490
-0.055 (-3.56%)
Sep 25, 2026, 1:43 PM EDT - Market open
Enveric Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8.3 | 4.68 | 2.24 | 2.29 | 17.72 | 17.36 |
Cash & Short-Term Investments | 8.3 | 4.68 | 2.24 | 2.29 | 17.72 | 17.36 |
Cash Growth | 191.12% | 108.72% | -2.05% | -87.09% | 2.12% | 999.55% |
Other Receivables | - | - | - | 0.22 | - | - |
Receivables | - | - | - | 0.22 | - | - |
Inventory | 0.07 | 0.05 | - | - | - | - |
Prepaid Expenses | 0.42 | 0.17 | 0.26 | 0.26 | 0.55 | 0.38 |
Other Current Assets | 0.01 | 0.05 | 0.23 | 0.81 | 0.16 | - |
Total Current Assets | 8.79 | 4.94 | 2.73 | 3.58 | 18.43 | 17.74 |
Property, Plant & Equipment | 0.08 | 0.16 | 0.31 | 0.51 | 0.74 | 0.47 |
Goodwill | - | - | - | - | - | 1.59 |
Other Intangible Assets | - | - | 0.04 | 0.21 | 0.38 | 6.92 |
Total Assets | 8.94 | 5.1 | 3.08 | 4.3 | 19.55 | 26.72 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.68 | 0.58 | 0.52 | 1.22 | 0.46 | 0.68 |
Accrued Expenses | 0.18 | 0.34 | 0.97 | 0.76 | 1.71 | 1.29 |
Current Portion of Leases | - | - | - | - | 0.06 | 0.11 |
Other Current Liabilities | - | - | - | 0.37 | 1.76 | - |
Total Current Liabilities | 0.86 | 0.92 | 1.49 | 2.34 | 4 | 2.08 |
Long-Term Leases | - | - | - | - | - | 0.07 |
Long-Term Deferred Tax Liabilities | - | - | - | - | - | 1.61 |
Other Long-Term Liabilities | - | - | - | - | - | 0.65 |
Total Liabilities | 0.86 | 0.92 | 1.49 | 2.34 | 4 | 4.41 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.04 | 0.01 | 0 | 0 | 0.02 | 0.01 |
Additional Paid-In Capital | 128.15 | 119.59 | 108.26 | 100.84 | 94.4 | 83.07 |
Retained Earnings | -119.51 | -114.85 | -106.07 | -96.5 | -79.21 | -60.74 |
Comprehensive Income & Other | -0.59 | -0.58 | -0.59 | -2.39 | -0.54 | -0.03 |
Total Common Equity | 8.08 | 4.18 | 1.59 | 1.96 | 14.67 | 22.31 |
Minority Interest | - | - | - | - | 0.89 | - |
Shareholders' Equity | 8.08 | 4.18 | 1.59 | 1.96 | 15.56 | 22.31 |
Total Liabilities & Equity | 8.94 | 5.1 | 3.08 | 4.3 | 19.55 | 26.72 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | - | - | - | 0.06 | 0.18 |
Net Cash (Debt) | 8.3 | 4.68 | 2.24 | 2.29 | 17.66 | 17.18 |
Net Cash Growth | 191.12% | 108.72% | -2.05% | -87.04% | 2.80% | 988.38% |
Net Cash Per Share | 5.14 | 13.97 | 53.47 | 190.74 | - | - |
Filing Date Shares Outstanding | 4.48 | 1.89 | 0.21 | 0.04 | 0.01 | 0.01 |
Total Common Shares Outstanding | 3.94 | 1.06 | 0.06 | 0.02 | 0.01 | 0 |
Working Capital | 7.93 | 4.02 | 1.24 | 1.24 | 14.44 | 15.65 |
Book Value Per Share | 2.05 | 3.94 | 28.19 | 128.55 | 1270.74 | 6161.86 |
Tangible Book Value | 8.08 | 4.18 | 1.55 | 1.75 | 14.29 | 13.79 |
Tangible Book Value Per Share | 2.05 | 3.94 | 27.44 | 114.69 | 1237.85 | 3810.60 |
Machinery | 0.81 | 0.83 | 0.8 | 0.87 | 0.86 | 0.32 |